Japanese Tobacco Stock News

TSE:6920
TSE:6920Semiconductor

How Investors Are Reacting To Lasertec (TSE:6920) Upgraded Guidance And Higher Dividend Payout

Lasertec Corporation reported half-year results to December 31, 2025, with sales of ¥128,258 million and net income of ¥45,745 million, alongside announcing a second-quarter dividend increase to ¥132.00 per share from ¥115.00 a year earlier, payable on March 12, 2026. The company also raised its full-year fiscal 2026 guidance, citing earlier customer acceptance of products and a revised yen/US$ exchange rate assumption of ¥145 per US$ compared with ¥135 previously. We will examine how...
TSE:4901
TSE:4901Tech

FUJIFILM Holdings (TSE:4901) Valuation After Earnings Growth Guidance Update And Affirmed Dividend

What the latest earnings, guidance and dividend signal for investors FUJIFILM Holdings (TSE:4901) has given investors a fresh information set, combining third quarter and nine month earnings, new full year guidance for fiscal 2026, and an affirmed year end dividend outlook. The company reported third quarter sales of ¥857,354 million and net income of ¥73,143 million, alongside nine month sales of ¥2,429,717 million and net income of ¥193,375 million, each higher than the comparable period a...
TSE:4503
TSE:4503Pharmaceuticals

Assessing Astellas Pharma (TSE:4503) Valuation After Myrbetriq Patent Settlements With Lupin And Zydus

Why the Myrbetriq legal settlement matters for Astellas shareholders Astellas Pharma (TSE:4503) has just closed its U.S. patent disputes over overactive bladder drug Myrbetriq, securing settlement and upfront licensing payments from Lupin and Zydus, as well as ongoing per unit fees. For you as an investor, this combination of cash inflows and reduced legal uncertainty can influence how you view the earnings profile tied to Myrbetriq and its generic competition in the U.S. market. See our...
TSE:8136
TSE:8136Specialty Retail

Sanrio Company (TSE:8136) Valuation After Upgraded Earnings And Dividend Guidance

Sanrio Company (TSE:8136) has put investors on alert after a February 12 board meeting combined three shareholder focused moves: an upcoming stock split, higher full year earnings guidance, and an increased dividend forecast. See our latest analysis for Sanrio Company. Despite Sanrio’s stronger guidance and dividend outlook, the share price is currently ¥4,764, with a 3 month share price return of an 18% decline and a 1 year total shareholder return of a 22% decline, while the 5 year total...
TSE:4204
TSE:4204Industrials

Is Sekisui Chemical’s Completed ¥26.4b Buyback Altering The Investment Case For Sekisui Chemical (TSE:4204)?

Sekisui Chemical has now completed its previously announced share repurchase plan, buying back 10,000,000 shares (2.43% of shares) for ¥26,420.48 million by February 9, 2026. This completed buyback reduces the share count and may enhance per-share metrics, underlining management’s willingness to return capital to investors. Next, we’ll examine how the completion of this sizeable buyback program may influence Sekisui Chemical’s existing investment narrative. We've uncovered the 14 dividend...
TSE:9434
TSE:9434Wireless Telecom

SoftBank’s Earnings per Share Gains Might Change The Case For Investing In SoftBank (TSE:9434)

SoftBank Corp. has reported past earnings for the nine months ended December 31, 2025, with sales of ¥5.20 trillion and net income of ¥485.52 billion, both higher than the previous year. The improvement in basic and diluted earnings per share from continuing operations suggests greater profit generation per share, which may influence how investors assess SoftBank’s earnings power. We’ll now examine how this growth in sales and net income shapes SoftBank’s broader investment narrative and...
TSE:4755
TSE:4755Multiline Retail

Is Rakuten (TSE:4755) Recasting Its Investment Story With 2026 Guidance Excluding Securities Revenue?

In February 2026, Rakuten Group, Inc. held a board meeting that resulted in no dividend payment decision for the 29th fiscal year and discussed its shareholder benefit program, while also hosting its Q4 2025 earnings call. A day later, the company issued consolidated earnings guidance for 2026, aiming for high single-digit revenue growth excluding its securities business, giving investors clearer visibility into its operational focus. We’ll now examine how this new 2026 revenue guidance,...